Cadence Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q4
Sell
-8,490
Closed -$629K 667
2015
Q3
$629K Buy
+8,490
New +$629K 0.04% 413